For entrepreneurs and project holders looking for financing, Genopole can accompany you on your pathway and propose programs uniquely available for biocluster entities.
We provide counseling during the preparation, negotiation and contract formalization phases with national and international investors. To maximize your chances of success, our project managers will provide coaching and help you develop a road show that valorizes your business strategy.
Public aids such as grants, unsecured loans, research tax credits or repayable advances for start-ups are numerous, but their conditions for attribution are sometimes quite complex. Our project managers, working closely with Bpifrance, Réseau Entreprendre, Wilco or other structures, will help you structure your public aid request, construct your dossier and prepare your oral presentation to investors. Their personalized and targeted assistance will maximize your chances of obtaining these important financing vehicles.
Note also that Genopole organizes meetings with Bpifrance twice or thrice yearly so that companies can exchange with their project managers.
Strengthen your R&D team with the Postdoctoral Allocation Program
For heads of biocluster companies looking to carry out a research project in their organization, Genopole has developed the Postdoctoral Repatriation Allocation Program. With its budget of €130,000, the program provides two years of funding for the salary of a young French-trained postdoc, who, after a postdoctoral position abroad, is seeking to return to France.
Genopole proposes several types of financing for researchers, postdocs and students:
For young researchers who earned their PhDs in France, went abroad for a postdoctoral position and now wish to return to France, Genopole created the Postdoctoral Repatriation Allocation Program. With its budget of €130,000, the allocation funds the salary of these young researchers for two years when they accept a research post within a Genopole laboratory or company.
The Genopole Thematic Actions Incentives (Atiges)
For researchers with public institution training, the Atiges offer the possibility of creating a team within a biocluster research unit. Atige recipients are selected by a scientific committee from candidates responding to a yearly call for candidates made by Genopole. The laureates receive €250,000 over three years with the possibility of funding for technicians, engineers or postdocs needed for constituting a team.
- Master 2
Students having completed a French first-year Master program or equivalent (e.g., Bachelor) with a French academic mention of Assez Bien or equivalent (e.g., ≈ Cum Laude) in research fields of interest to Genopole, particularly genomics, innovative therapies and bioinformatics, are eligible for Master 2 internship scholarships. The recipients are chosen based on the scientific quality of their project and are allocated €3,500 by Genopole to cover six months of internship remuneration.
- High-level training
Genopole created the endowment fund Fondagen to finance high-level international training for PhD students, the Postdoctoral Repatriation Allocation Program and chairs for young researchers. Fondagen grants are attributed by a selection commission.
Cultivate and diffuse innovation in hospitals
GIP Genopole is committed to biomedical research and convinced that innovation must be focused on professional needs and real-world use. Its partnership with the South Île-de-France Medical Center (CHSF), a 1,000-bed pandisciplinary hospital located at the heart of the biocluster, gives Genopole’s researchers and entrepreneurs a privileged opportunity to better understand the concrete needs of patients, healthcare providers and hospital executives.
With the actions it deploys, GIP Genopole aims to:
- strengthen partnerships between researchers and hospital teams;
- ease the launch and completion of clinical studies;
- encourage research by hospital practitioners and projects at the crossroads of academic research and hospital practice, particularly via its annual call for candidates for biomedical research grants;
- favor the emergence of novel, hospital-grown solutions with its Genopole-CHSF call for innovative ideas.